Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology

Comment

Sam S Chang. J Urol. 2023 Dec.

. 2023 Dec;210(6):928-930.

doi: 10.1097/JU.0000000000003719. Epub 2023 Sep 25.

No abstract available

Comment on

Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial.
Angulo JC, Álvarez-Ossorio JL, Domínguez-Escrig JL, Moyano JL, Sousa A, Fernández JM, Gómez-Veiga F, Unda M, Carballido J, Carrero V, Fernandez-Aparicio T, García de Jalón Á, Solsona E, Inman B, Palou J. Angulo JC, et al. Eur Urol Oncol. 2023 Feb;6(1):58-66. doi: 10.1016/j.euo.2022.10.008. Epub 2022 Nov 23. Eur Urol Oncol. 2023. PMID: 36435738 Clinical Trial.
Oncologic outcomes of neoadjuvant chemotherapy in patients with micropapillary variant urothelial carcinoma of the bladder.
Rahman SN, Lokeshwar SD, Syed JS, Javier-Desloges JF, Press BH, Choksi AU, Rajwa P, Pradere B, Ploussard G, Kim JW, Monaghan TF, Renzulli JR, Shariat SF, Leapman MS. Rahman SN, et al. Urol Oncol. 2023 Feb;41(2):107.e1-107.e8. doi: 10.1016/j.urolonc.2022.09.008. Epub 2022 Dec 5. Urol Oncol. 2023. PMID: 36481253
Natural History of Multiple Recurrences in Intermediate-Risk Non-Muscle Invasive Bladder Cancer: Lessons From a Prospective Cohort.
Sharma V, Chamie K, Schoenberg M, Lee VS, Fero K, Lec P, Munneke JR, Aaronson DS, Kushi LH, Quesenberry CP, Tang L, Kwan ML. Sharma V, et al. Urology. 2023 Mar;173:134-141. doi: 10.1016/j.urology.2022.12.009. Epub 2022 Dec 24. Urology. 2023. PMID: 36574911 Free PMC article.